Mayne Pharma Group Ltd (FRA:HG6)
€ 2.92 0 (0%) Market Cap: 247.26 Mil Enterprise Value: 179.89 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 75/100

Mayne Pharma Group Ltd Annual Shareholders Meeting Transcript

Nov 29, 2023 / 11:00PM GMT
Release Date Price: €3.1
Frank Condella Mayne Pharma Group Ltd;Chair

Welcome, everyone. I'm Frank Condella, Chair of Mayne Pharma. It's my pleasure to welcome you to Mayne Pharma's 2023 Annual General Meeting. As we have a quorum, I now open the meeting. Once again, this year we are offering a hybrid meeting, allowing shareholders to participate in person or via webcast.

You'll see on the screen here our disclaimer statement, I'd ask you take note of it before we get started. I'd also like to say that personally, I usually don't like reading from a script, but since this has now been given to ASX, I've got to stick to it until we get to the question, sorry that you'll see me reading a lot.

Let me first take a moment to walk you through the procedural aspects of today's meeting. Shareholders and Proxyholders present in the room can ask questions. If you're watching on the webcast and are a shareholder, you have the ability to ask questions through the meeting platform. Questions can be submitted at any time, and you do not need to wait for the relevant item of business to ask your question.

To

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot